SS-31 (Elamipretide / MTP-131 | Mitochondrial Cardiolipin & Bioenergetics Studies)

Product Info

SS-31, also known as elamipretide, MTP-131, or Bendavia, is an investigational mitochondria-targeted tetrapeptide commonly discussed in mitochondrial-function, cellular-energy, oxidative-stress, cardiolipin, aging, muscle, heart, kidney, and neurodegenerative research.

SS-31 is a short synthetic peptide sequence often described as an aromatic-cationic tetrapeptide. Scientific interest centers on its ability to interact with cardiolipin, a phospholipid found in the inner mitochondrial membrane that plays an important role in mitochondrial structure, cristae organization, and electron transport chain function. Reviews describe SS-31/elamipretide as a mitochondria-targeted peptide studied for mitochondrial dysfunction through cardiolipin-related mechanisms.

Unlike metabolic peptides such as tirzepatide or retatrutide, SS-31 is not designed around GLP-1, GIP, glucagon, appetite, or glucose-control receptor activity. Scientific interest instead centers on mitochondrial membrane biology, cardiolipin stabilization, electron transport chain function, ATP-related research, oxidative-stress models, cellular-energy studies, and broader mitochondrial dysfunction research.

SS-31 should be understood as a research peptide only. While mitochondrial biology is highly important in aging, energy production, muscle function, organ stress, and degenerative-disease research, broad claims around energy improvement, anti-aging, disease treatment, athletic performance, fatigue reduction, or systemic human benefit remain insufficiently established for general human use.

Potential research interests observed in studies

• Mitochondrial cardiolipin research
  SS-31 is most commonly studied for its relationship with cardiolipin in the inner mitochondrial membrane. Cardiolipin is important for mitochondrial structure and electron transport chain activity, making SS-31 a major research peptide in mitochondrial-membrane and cristae-stability models.

• Electron transport chain research
  Because cardiolipin helps support electron transport chain organization, SS-31 is frequently discussed in research involving mitochondrial respiration, electron flow, and energy-production efficiency under cellular stress conditions.

• ATP and cellular-energy studies
  SS-31 is commonly discussed in bioenergetics research because mitochondrial function is closely tied to ATP production. Research interest includes how mitochondrial membrane stability and electron transport chain efficiency may influence cellular-energy output in stress models.

• Oxidative-stress research
  Scientific discussion around SS-31 often includes oxidative-stress pathways, reactive oxygen species signaling, and mitochondrial damage models. This should be understood as a research interest, not a confirmed antioxidant or anti-aging benefit in humans.

• Mitochondrial dysfunction models
  SS-31 is frequently studied in models of mitochondrial dysfunction, where impaired mitochondrial structure, electron transport, oxidative stress, or energy production may be involved. These models may include organ-stress, metabolic-stress, age-related, and degenerative-research contexts.

• Heart and cardiovascular research
  SS-31/elamipretide has been discussed in cardiovascular and ischemia-reperfusion research because heart tissue has high energy demand and is highly dependent on mitochondrial function. These findings should not be presented as proven cardiovascular treatment outcomes.

• Kidney and organ-stress research
  Mitochondrial dysfunction is often studied in kidney and organ-stress models. SS-31 is of interest in these settings because of its proposed relationship with mitochondrial membrane function and oxidative-stress response.

• Muscle and exercise-related research
  Because skeletal muscle depends heavily on mitochondrial energy production, SS-31 is commonly discussed in muscle-function, fatigue, endurance, and mitochondrial-capacity research. This should not be marketed as a proven performance enhancer or fatigue treatment.

• Neurodegenerative and brain-energy research
  SS-31 is also discussed in neurodegenerative and brain-energy models because neurons are highly dependent on mitochondrial health. Research interest includes mitochondrial stress, oxidative injury, and cellular-energy regulation in nervous-system models.

• Aging and longevity research interest
  SS-31 has become popular in longevity and mitochondrial-health discussions because mitochondrial dysfunction is commonly linked with aging biology. However, many consumer-facing claims around "anti-aging," "energy," or "longevity" go beyond what controlled human evidence can firmly establish.

Limitations and risks observed or discussed

• Human clinical evidence is still limited
  SS-31 has strong mechanistic relevance in mitochondrial and cardiolipin research, but broad human claims around energy, anti-aging, fatigue, endurance, organ repair, neuroprotection, cardiovascular support, or longevity still require stronger controlled clinical evidence.

• Not an approved medication for general mitochondrial treatment
  SS-31 should not be marketed as a treatment for fatigue, mitochondrial disease, heart disease, kidney disease, neurodegeneration, muscle weakness, aging, low energy, exercise intolerance, or any medical condition.

• Mitochondrial claims can be easily overstated
  Mitochondria are involved in many biological processes, but that does not mean a mitochondrial-targeted peptide has proven broad benefits in humans. Research discussion should avoid implying general wellness, anti-aging, or performance outcomes.

• Route of use matters
  Controlled laboratory or clinical-research settings are different from unapproved research-grade products. Research-grade or unapproved peptide products should not be used in humans, especially by injection.

• Disease-specific research should not be generalized
  SS-31/elamipretide has been studied in specialized mitochondrial and organ-dysfunction contexts, but findings from specific research settings should not be generalized into broad consumer treatment claims.

Website-safe closing line

SS-31 is scientifically interesting for mitochondrial cardiolipin research, electron transport chain function, oxidative-stress models, ATP-related bioenergetics, organ-stress research, muscle-function studies, neurodegenerative models, and broader mitochondrial-dysfunction research, but broad human safety and effectiveness claims remain insufficiently established. SS-31 should not be marketed as a treatment for any medical condition, and unapproved human use should be avoided. Sterile Labs products are strictly for research use only.